From evidence to adoption: How real-world data is powering digital health success Digital Health In today’s outcomes-driven healthcare landscape, real-world data (RWD) and real-world evidence (RWE) have emerged as critical tools to demonstrate clinical value, return on investment (ROI) and long-term impact beyond controlled trial environments. High-quality, analysis-ready data on real-world effectiveness is no longer…

Upping the Migraine Intelligence Quotient: Real-world data sheds light on prevalence rates, providers and treatment variation Life Sciences  Introduction Headache disorders including migraine are highly prevalent globally, estimated to affect more than 50% of the population at any point and time. In the U.S., migraine patients spend an average of $9,000 more than those without…

Unlock the Value of Effective Treatments: Discover how life sciences leaders can optimize patient outcomes and healthcare costs by addressing key questions about treatment adherence, healthcare utilization, and cost reduction.

An Antidote to Long-Standing Care and Cost Outcomes Analysis Frustrations Life Sciences Download

The fact that healthcare organizations need to improve care outcomes is undeniably undisputed. To succeed, health plan leaders need to acknowledge that medical care is estimated to account for only 10% to 20% of the modifiable contributors to healthy outcomes for a population. The other 80% to 90% emanates from social determinants of health (SDOH),…

Introduction In today’s highly competitive healthcare marketing industry, marketers need to take a strategic approach to audience development that accounts for the intersection of factors that impact the provider’s ability to treat the patient, the marketer’s capacity to engage the attention of the healthcare provider, and the “knowability” of these factors. Drawing from the work…

The COVID-19 pandemic underscored the necessity for healthcare organizations to adapt swiftly. This was particularly evident with the rapid adoption of telehealth. For instance, in the first quarter of 2020, telehealth visits surged by 50% compared to 2019. As COVID-19 becomes endemic, healthcare leaders face crucial decisions on the strategic use of telehealth versus in-person…

Cookie-less Marketing for Pharmaceuticals and the Role of Real-World Data (RWD) Life Sciences Pharmaceutical marketing is undergoing a significant transformation as third-party cookies become obsolete. To navigate this shift, pharmaceutical companies must embrace cookie-less marketing strategies, leveraging real-world data throughout the advertising campaign lifecycle.  In this whitepaper, we explore: The impact of cookie-less marketing on…

Impact of Applying SDOH on Prescription Fill Rate Analysis Life Sciences This whitepaper highlights the significance of understanding prescription rejection rates, particularly for specialty pharmacy medications, and the role of plan design and social determinants of health (SDOH) in determining eligibility and out-of-pocket costs for patients.   Traditional analyses focusing solely on demographics like age and…